Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: a follow-up study in PNET 3 trial survivors on behalf of the CCLG (formerly UKCCSG).

MLA

Bull KS, et al. “Reduction of Health Status 7 Years after Addition of Chemotherapy to Craniospinal Irradiation for Medulloblastoma: A Follow-up Study in PNET 3 Trial Survivors on Behalf of the CCLG (Formerly UKCCSG).” Journal of Clinical Oncology, vol. 25, no. 27, Sept. 2007, pp. 4239–45. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=105953782&authtype=sso&custid=ns315887.

APA

Bull KS, Spoudeas HA, Yadegarfar G, Kennedy CR, Cclg, Bull, K. S., Spoudeas, H. A., Yadegarfar, G., & Kennedy, C. R. (2007). Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: a follow-up study in PNET 3 trial survivors on behalf of the CCLG (formerly UKCCSG). Journal of Clinical Oncology, 25(27), 4239–4245.

Chicago

Bull KS, Spoudeas HA, Yadegarfar G, Kennedy CR, Cclg, Kim S Bull, Helen A Spoudeas, Ghasem Yadegarfar, and Colin R Kennedy. 2007. “Reduction of Health Status 7 Years after Addition of Chemotherapy to Craniospinal Irradiation for Medulloblastoma: A Follow-up Study in PNET 3 Trial Survivors on Behalf of the CCLG (Formerly UKCCSG).” Journal of Clinical Oncology 25 (27): 4239–45. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=105953782&authtype=sso&custid=ns315887.